중국, 세계 최초 침습형 BCI 승인 — 그런데 왜 Neuralink가 아닐까?
중국 국가약품감독관리국이 척수손상 환자를 위한 Neuracle의 Neo 뇌 임플란트를 승인하며 Neuralink보다 먼저 시장에 진출, 최초의 침습형 BCI 허가를 획득했다.
china approved the neo device, developed by neuracle technology and tsinghua university, for patients with quadriplegia due to spinal cord injuries, marking the first regulatory green light for an invasive bci globally. the system uses sensors placed on the brain's outer membrane to interpret signals and drive external robotics, offering a safer profile than neuralink's penetrating threads by reducing hemorrhage risk. this milestone highlights china's accelerated regulatory pathway for neurotech, granting it a first-mover advantage in the commercial bci market ahead of us competitors.